SUNNYVALE, Calif.--(BUSINESS WIRE)--Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein, today announced Mark J. Benedyk, PhD will join the Company as a strategic advisor effective immediately. Dr. Benedyk is a seasoned life sciences executive with an extensive background in pharmaceutical licensing, operations and corporate development. In this role, he will support Amarantus on strategy and business development issues.
